Other Species / Isoforms
  PKCI (rat)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T3
_____MPTQRDSSTM
0 1
PKCI (human) _____MPtQRDsstM T3-p
PKCI (mouse) _____MPTQRDsSTM T3
PKCI (rat) _____MPTQRDSSTM T3
S7
_MPTQRDSSTMSHTV
0 3
PKCI (human) _MPtQRDsstMsHtV S7-p
PKCI (mouse) _MPTQRDsSTMsHTV S7-p
PKCI (rat) _MPTQRDSSTMSHTV S7
S8
MPTQRDSSTMSHTVA
0 2
PKCI (human) MPtQRDsstMsHtVA S8-p
PKCI (mouse) MPTQRDsSTMsHTVA S8
PKCI (rat) MPTQRDSSTMSHTVA S8
T9
PTQRDSSTMSHTVAC
0 2
PKCI (human) PtQRDsstMsHtVAG T9-p
PKCI (mouse) PTQRDsSTMsHTVAC T9
PKCI (rat) PTQRDSSTMSHTVAC T9
S11
QRDSSTMSHTVACGG
0 3
PKCI (human) QRDsstMsHtVAGGG S11-p
PKCI (mouse) QRDsSTMsHTVACGG S11-p
PKCI (rat) QRDSSTMSHTVACGG S11
T13
DSSTMSHTVACGGGG
0 1
PKCI (human) DsstMsHtVAGGGsG T13-p
PKCI (mouse) DsSTMsHTVACGGGG T13
PKCI (rat) DSSTMSHTVACGGGG T13
G19
HTVACGGGGDHSHQV
0 5
PKCI (human) HtVAGGGsGDHSHQV S19-p
PKCI (mouse) HTVACGGGGDHSHQV G19
PKCI (rat) HTVACGGGGDHSHQV G19
S44
MITHFEPSISFEGLC
1 1
PKCI (human) MITHFEPsIsFEGLC S44-p
PKCI (mouse) MITHFEPSISFEGLC S44
PKCI (rat) MITHFEPSISFEGLC S44
S46
THFEPSISFEGLCSE
1 1
PKCI (human) THFEPsIsFEGLCNE S46-p
PKCI (mouse) THFEPSISFEGLCSE S46
PKCI (rat) THFEPSISFEGLCSE S46
S59
SEVRDMCSFDNEQPF
0 1
PKCI (human) NEVRDMCsFDNEQLF S59-p
PKCI (mouse) SEVRDMCSFDNEQPF S59
PKCI (rat) SEVRDMCSFDNEQPF S59
S82
GDPCTVSSQLELEEA
0 1
PKCI (human) GDPCTVSsQLELEEA S82-p
PKCI (mouse) GDPCTVSSQLELEEA S82
PKCI (rat) GDPCTVSSQLELEEA S82
Y125
PGEDKSIYRRGARRW
0 1
PKCI (human) PGEDKSIyRRGARRW Y125-p
PKCI (mouse) PGEDKSIYRRGARRW Y125
PKCI (rat) PGEDKSIYRRGARRW Y125
K134
RGARRWRKLyCANGH
0 1
PKCI (human) RGARRWRkLyCANGH K134-ac
PKCI (mouse) RGARRWRKLyCANGH K134
PKCI (rat) RGARRWRKLyCANGH K134
Y136-p
ARRWRKLyCANGHTF
0 60
PKCI (human) ARRWRkLyCANGHtF Y136-p
PKCI (mouse) ARRWRKLyCANGHTF Y136-p
PKCI (rat) ARRWRKLyCANGHTF Y136-p
T142
LyCANGHTFQAKRFN
0 1
PKCI (human) LyCANGHtFQAKRFN T142-p
PKCI (mouse) LyCANGHTFQAKRFN T142
PKCI (rat) LyCANGHTFQAKRFN T142
K175
GYKCINCKLLVHKKC
0 1
PKCI (human) GYKCINCkLLVHKKC K175-ac
PKCI (mouse) GYKCINCKLLVHKKC K175
PKCI (rat) GYKCINCKLLVHKKC K175
K184
LVHKKCHKLVTIECG
0 1
PKCI (human) LVHKKCHkLVTIECG K184-ub
PKCI (mouse) LVHKKCHKLVTIECG K184
PKCI (rat) LVHKKCHKLVTIECG K184
S206
PMMPMDQSSMHPDHT
0 1
PKCI (human) PVMPMDQSSMHSDHA S206
PKCI (mouse) PMMPMDQtMHPDHtQ T206-p
PKCI (rat) PMMPMDQSSMHPDHT S206
T213
SSMHPDHTQTVIPYN
0 1
PKCI (human) SSMHSDHAQTVIPyN A213
PKCI (mouse) QtMHPDHtQTVIPYN T212-p
PKCI (rat) SSMHPDHTQTVIPYN T213
Y219
HTQTVIPYNPSSHES
0 1
PKCI (human) HAQTVIPyNPssHEs Y219-p
PKCI (mouse) HtQTVIPYNPSSHES Y218
PKCI (rat) HTQTVIPYNPSSHES Y219
S222
TVIPYNPSSHESLDQ
1 1
PKCI (human) TVIPyNPssHEsLDQ S222-p
PKCI (mouse) TVIPYNPSSHESLDQ S221
PKCI (rat) TVIPYNPSSHESLDQ S222
S223
VIPYNPSSHESLDQV
1 1
PKCI (human) VIPyNPssHEsLDQV S223-p
PKCI (mouse) VIPYNPSSHESLDQV S222
PKCI (rat) VIPYNPSSHESLDQV S223
S226
YNPSSHESLDQVGEE
1 1
PKCI (human) yNPssHEsLDQVGEE S226-p
PKCI (mouse) YNPSSHESLDQVGEE S225
PKCI (rat) YNPSSHESLDQVGEE S226
K234
LDQVGEEKEAMNTRE
0 1
PKCI (human) LDQVGEEkEAMNTRE K234-sm
PKCI (mouse) LDQVGEEKEAMNTRE K233
PKCI (rat) LDQVGEEKEAMNTRE K234
K244
MNTRESGKASSSLGL
0 3
PKCI (human) MNTRESGkAssSLGL K244-ub
PKCI (mouse) MNTRESGkASSSLGL K243-ub
PKCI (rat) MNTRESGKASSSLGL K244
S246
TRESGKASSSLGLQD
1 2
PKCI (human) TRESGkAssSLGLQD S246-p
PKCI (mouse) TRESGkASSSLGLQD S245
PKCI (rat) TRESGKASSSLGLQD S246
S247
RESGKASSSLGLQDF
1 3
PKCI (human) RESGkAssSLGLQDF S247-p
PKCI (mouse) RESGkASSSLGLQDF S246
PKCI (rat) RESGKASSSLGLQDF S247
Y265-p
RVIGRGSyAKVLLVR
Upstream
Downstream
2 0
Effects on Modified Protein
  • intracellular localization
Kinase, in vitro:
  • Src (human)
Putative in vivo kinases:
  • Src (human)
Treatment
  • genistein
  • K252a
  • NGF
  • PP2
PKCI (human) RVIGRGSYAKVLLVR Y265
PKCI (mouse) RVIGRGSYAKVLLVR Y264
PKCI (rat) RVIGRGSyAKVLLVR Y265-p
Y280-p
LKKTDRIyAMKVVKK
Upstream
1 0
Kinase, in vitro:
  • Src (human)
Treatment
  • genistein
  • K252a
  • NGF
  • PP2
PKCI (human) LKKTDRIYAMKVVKk Y280
PKCI (mouse) LKKTDRIYAMKVVKK Y279
PKCI (rat) LKKTDRIyAMKVVKK Y280-p
K287
yAMKVVKKELVNDDE
0 1
PKCI (human) YAMKVVKkELVNDDE K287-ub
PKCI (mouse) YAMKVVKKELVNDDE K286
PKCI (rat) yAMKVVKKELVNDDE K287
Y334-p
RLFFVIEyVNGGDLM
Upstream
Downstream
1 0
Effects on Modified Protein
  • activity, induced
Kinase, in vitro:
  • Src (human)
Treatment
  • genistein
  • K252a
  • NGF
  • PP2
PKCI (human) RLFFVIEYVNGGDLM Y334
PKCI (mouse) RLFFVIEYVNGGDLM Y333
PKCI (rat) RLFFVIEyVNGGDLM Y334-p
R377
HERGIIYRDLKLDNV
0 2
PKCI (human) HERGIIYRDLkLDNV R377
PKCI (mouse) HERGIIYrDLkLDNV R376-m1
PKCI (rat) HERGIIYRDLKLDNV R377
K380
GIIYRDLKLDNVLLD
0 2
PKCI (human) GIIYRDLkLDNVLLD K380-ub
PKCI (mouse) GIIYrDLkLDNVLLD K379-ub
PKCI (rat) GIIYRDLKLDNVLLD K380
Y397
GHIKLTDYGMCKEGL
0 1
PKCI (human) GHIKLTDyGMCKEGL Y397-p
PKCI (mouse) GHIKLTDYGMCKEGL Y396
PKCI (rat) GHIKLTDYGMCKEGL Y397
T409
EGLRPGDTTStFCGT
0 3
PKCI (human) EGLRPGDttstFCGt T409-p
PKCI (mouse) EGLRPGDttstFCGt T408-p
PKCI (rat) EGLRPGDTTStFCGT T409
T410
GLRPGDTTStFCGTP
0 5
PKCI (human) GLRPGDttstFCGtP T410-p
PKCI (mouse) GLRPGDttstFCGtP T409-p
PKCI (rat) GLRPGDTTStFCGTP T410
S411
LRPGDTTStFCGTPN
1 13
PKCI (human) LRPGDttstFCGtPN S411-p
PKCI (mouse) LRPGDttstFCGtPN S410-p
PKCI (rat) LRPGDTTStFCGTPN S411
T412-p
RPGDTTStFCGTPNY
Upstream
9 49
PKCI (human)
T412-p
PKCI (mouse)
T411-p
PKCI (rat)
T412-p
Treatment
  • long-term_potentiation
PKCI (human) RPGDttstFCGtPNy T412-p
PKCI (mouse) RPGDttstFCGtPNY T411-p
PKCI (rat) RPGDTTStFCGTPNY T412-p
T416
TTStFCGTPNYIAPE
1 10
PKCI (human) ttstFCGtPNyIAPE T416-p
PKCI (mouse) ttstFCGtPNYIAPE T415-p
PKCI (rat) TTStFCGTPNYIAPE T416
Y419
tFCGTPNYIAPEILR
0 2
PKCI (human) tFCGtPNyIAPEILR Y419-p
PKCI (mouse) tFCGtPNYIAPEILR Y418
PKCI (rat) tFCGTPNYIAPEILR Y419
Y430
EILRGEDYGFSVDWW
1 0
PKCI (human) EILRGEDyGFSVDWW Y430-p
PKCI (mouse) EILRGEDYGFSVDWW Y429
PKCI (rat) EILRGEDYGFSVDWW Y430
S459
PFDIVGSSDNPDQNT
1 1
PKCI (human) PFDIVGSsDNPDQNT S459-p
PKCI (mouse) PFDIVGSSDNPDQNT S458
PKCI (rat) PFDIVGSSDNPDQNT S459
K477
LFQVILEKQIRIPRS
0 1
PKCI (human) LFQVILEkQIRIPRS K477-ub
PKCI (mouse) LFQVILEKQIRIPRS K476
PKCI (rat) LFQVILEKQIRIPRS K477
K488-ac
IPRSLSVkAASVLKS
0 1
PKCI (human) IPRSLSVKAASVLKS K488
PKCI (mouse) IPRSLSVKAASVLKS K487
PKCI (rat) IPRSLSVkAASVLKS K488-ac
K488
IPRSLSVKAASVLKS
0 4
PKCI (human) IPRSLSVkAASVLKS K488-ub
PKCI (mouse) IPRSLSVKAASVLKS K487
PKCI (rat) IPRSLSVKAASVLKS K488
K499
VLKSFLNKDPKERLG
0 1
PKCI (human) VLKSFLNkDPKERLG K499-ub
PKCI (mouse) VLKSFLNKDPKERLG K498
PKCI (rat) VLKSFLNKDPKERLG K499
T557
DNFDSQFTNEPVQLt
0 1
PKCI (human) DNFDSQFtNEPVQLt T557-p
PKCI (mouse) DNFDSQFTNEPVQLt T556
PKCI (rat) DNFDSQFTNEPVQLt T557
T564-p
TNEPVQLtPDDDDIV
Upstream
7 28
Treatment
  • long-term_potentiation
PKCI (human) tNEPVQLtPDDDDIV T564-p
PKCI (mouse) TNEPVQLtPDDDDIV T563-p
PKCI (rat) TNEPVQLtPDDDDIV T564-p
Y584
SEFEGFEYINPLLMS
0 9
PKCI (human) SEFEGFEyINPLLMs Y584-p
PKCI (mouse) SEFEGFEYINPLLMs Y583
PKCI (rat) SEFEGFEYINPLLMS Y584
S591
YINPLLMSAEECV__
1 6
PKCI (human) yINPLLMsAEECV__ S591-p
PKCI (mouse) YINPLLMsAEECV__ S590-p
PKCI (rat) YINPLLMSAEECV__ S591